Higher thymocyte selection-associated high mobility group box (TOX) expression predicts poor prognosis in patients with ovarian cancer
Abstract Background Ovarian cancer is one of the most lethal gynecologic malignancies with a dismal prognosis that poses a serious threat to human health, highlighting the need for more knowledge about what is required for identifying some biomarkers for early diagnosis, prediction of prognosis and...
Main Authors: | Sai Li, Sifu Yang, Yupeng Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-10336-6 |
Similar Items
-
TOX regulates T lymphocytes differentiation and its function in tumor
by: Haiyue Niu, et al.
Published: (2023-03-01) -
The pangenome of the wheat pathogen Pyrenophora tritici-repentis reveals novel transposons associated with necrotrophic effectors ToxA and ToxB
by: Ryan Gourlie, et al.
Published: (2022-10-01) -
An Evolved Transformer Model for ADME/Tox Prediction
by: Changheng Shao, et al.
Published: (2024-02-01) -
TOX Expression in Mycosis Fungoides and Sezary Syndrome
by: Alessandro Pileri, et al.
Published: (2022-06-01) -
Tox-positive Corynebacterium ulcerans in hedgehogs, Germany
by: Anja Berger, et al.
Published: (2019-01-01)